Results 111 to 120 of about 443,505 (210)

Influenza, RSV and Other Respiratory Viruses Surveillance Report: Week 50 2023 (11th– 17th December 2023)

open access: yes, 2023
This report presents data on the epidemiology of influenza, respiratory syncytial virus (RSV) and other respiratory viruses (ORVs).
Health Protection Surveillance Centre (HPSC)   +1 more
core  

Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic

open access: yesNature Communications
Respiratory Syncytial Virus (RSV) is a leading cause of acute respiratory tract infection, with the greatest impact on infants, immunocompromised individuals, and older adults.
Estefany Rios-Guzman   +10 more
doaj   +1 more source

Influenza, RSV and Other Respiratory Viruses Surveillance Report: Week 46 2023 (13th - 19th November 2023)

open access: yes, 2023
This report presents data on the epidemiology of influenza, respiratory syncytial virus (RSV) and other respiratory viruses (ORVs).
Health Protection Surveillance Centre (HPSC)   +1 more
core  

Severe Respiratory Syncytial Virus (RSV) Infection in Preterm Infants and Later Onset of Asthma

open access: yes, 2018
Respiratory Syncytial Virus (RSV)-hospitalizations have a substantial disease burden during an infant’s first year of life, and long-term consequences such as asthma remain unclear.
Jalink, Matthew
core  

Guideline for the diagnosis, treatment, and prevention of respiratory syncytial virus infection in children in China

open access: yesPediatric Investigation
Respiratory syncytial virus (RSV) is one of the most common respiratory pathogens in children under 5 years of age worldwide and it seriously threatens children's health. In recent years, great progress has been made in the field of RSV‐related diseases.
Committee of Pediatrics, China Medical Education Association   +9 more
doaj   +1 more source

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis

open access: yesExpert Review of Vaccines
Background Respiratory syncytial virus (RSV), a common respiratory pathogen, can lead to severe symptoms, especially in older adults (OA). A recently developed RSV prefusion F protein (RSVPreF3 OA) vaccine confers high protection against RSV lower ...
Daisuke Kurai   +7 more
doaj   +1 more source

Influenza, RSV and Other Respiratory Viruses Surveillance Report: Week 3 2024 (15th – 21st January 2024) [PDF]

open access: yes
This report presents data on the epidemiology of influenza, respiratory syncytial virus (RSV) and other respiratory viruses (ORVs).
Health Protection Surveillance Centre (HPSC)
core  

Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps

open access: yesPulmonary Therapy
Respiratory syncytial virus (RSV) is a significant global health concern and major cause of hospitalization, particularly among infants and older adults.
Ricardo Amorim Correa   +13 more
doaj   +1 more source

A comprehensive look at Respiratory Syncytial Virus (RSV): from pathogenesis to prevention

open access: yesTropical Diseases, Travel Medicine and Vaccines
Respiratory Syncytial Virus (RSV) is a formidable respiratory pathogen that particularly affects infants and children. RSV presents with diverse clinical severity, most often causing mild upper airway symptoms but sometimes progressing to severe and ...
Omid Salahi Ardekani   +8 more
doaj   +1 more source

Influenza, RSV and Other Respiratory Viruses Surveillance Report: Week 4 2024 (22nd – 28th January 2024) [PDF]

open access: yes
This report presents data on the epidemiology of influenza, respiratory syncytial virus (RSV) and other respiratory viruses (ORVs).
Health Protection Surveillance Centre (HPSC)
core  

Home - About - Disclaimer - Privacy